忍者ブログ

リリースコンテナ第3倉庫



Home > ブログ > > [PR] Home > ブログ > 未選択 > August 13, 2012 06:20 AM Eastern Daylight Time Research and Markets: Seborrhea - Pipeline Review, H1 2012

[PR]

×

[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。

August 13, 2012 06:20 AM Eastern Daylight Time Research and Markets: Seborrhea - Pipeline Review, H1 2012

Research and Markets (http://www.researchandmarkets.com/research/8cg3k7/seborrhea_pipeli) has announced the addition of Global Markets Direct's new report "Seborrhea - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Seborrhea - Pipeline Review, H1 2012', provides an overview of the Seborrhea therapeutic pipeline. This report provides information on the therapeutic development for Seborrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Seborrhea.

Scope

- A snapshot of the global therapeutic scenario for Seborrhea.

- A review of the Seborrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Seborrhea pipeline on the basis of route of administration and molecule type.

- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

- Key discontinued pipeline projects.

- News and deals relating to the products.

Reasons to Buy

- Identify and understand important and diverse types of therapeutics under development for Seborrhea.

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.

- Devise corrective measures for pipeline projects by understanding Seborrhea pipeline depth and focus of Seborrhea therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

For more information visit http://www.researchandmarkets.com/research/8cg3k7/seborrhea_pipeli

Source: Global Markets Direct

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

PR

Comment0 Comment

Comment Form

  • お名前name
  • タイトルtitle
  • メールアドレスmail address
  • URLurl
  • コメントcomment
  • パスワードpassword